^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Steroid receptor agonist

2d
New P4 trial • HEOR
|
dexamethasone injection
3d
New trial
|
Rituxan (rituximab) • prednisone • dexamethasone injection
3d
New trial
|
prednisone
3d
New trial
|
dexamethasone injection
3d
A Randomized Controlled Trial on the Efficacy of Tympanic Membrane Injection of PTMSC Exosomes in the Treatment of Sudden Deafness (ChiCTR2500115760)
P=N/A, N=88, Not yet recruiting, Zhujiang Hospital of Southern Medical University; Zhujiang Hospital of Southern Medical University
New trial
|
dexamethasone injection
3d
A Real-World Study of Nefecon in the Treatment of IgA Nephropathy After Kidney Transplantation (ChiCTR2500114867)
P=N/A, N=30, Not yet recruiting, Shanghai Changhai Hospital; Shanghai Changhai Hospital
New trial
3d
Comparison of the effect of different intravenous doses of dexmedetomidine in preventing shivering in cesarean section patients under spinal anesthesia: A clinical randomized controlled trial (ChiCTR2500112804)
P=N/A, N=192, Recruiting, The Second Affiliated Hospital of Guangdong Medical University; The Second Affiliated Hospital of Guangdong Medical University
New trial
|
dexamethasone injection
3d
New trial
|
dexamethasone injection
3d
Efficacy and safety evaluation of Nefecon combined with low-dose mycophenolate mofetil in the treatment of primary IgA nephropathy: a prospective, multicenter, single arm study (ChiCTR2500114440)
P=N/A, N=40, Recruiting, The first affiliated hostipal of nanchang university; The first affiliated hostipal of nanchang university
New trial
3d
The influence of CD27-CD21+ B cells and IgA plasma cell changes in patients with IgA nephropathy on the prognosis of treatment with Nefecon (ChiCTR2500115491)
P4, N=96, Not yet recruiting, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University; Shenzhen Second People's Hospital, The First Affiliated Hospi
New P4 trial
5d
Corticosteroid Effect on Achalasia Variant EGJOO (clinicaltrials.gov)
P1, N=12, Active, not recruiting, Baylor Research Institute | Trial completion date: Jan 2026 --> Nov 2026 | Trial primary completion date: Jan 2026 --> Nov 2026
Trial completion date • Trial primary completion date
|
prednisone
6d
Enrollment change